Latest Quarterly Financials News

Alpha HPA Limited reports significant progress on its HPA First Project Stage 2 with key infrastructure completed and engineering milestones met. Strong semiconductor sector demand drives Letters of Intent covering over 60% of Stage 2 production, while sapphire wafer production and leadership changes position the company for growth.

DXN Limited reported a modest 2% revenue increase to $2.5 million in Q3 FY25, launched its Data Centre as a Service division with a $3.6 million initial contract, and progressed a key acquisition valued at $10 million, positioning itself for growth despite some project delays.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

Atomos Limited reported a $2.3 million operating cash outflow in Q3 FY25 amid seasonal softness and tariff challenges, while announcing a leadership change and a bold expansion into new product categories beyond its core monitor-recorder business.

Perpetual Resources has completed a transformational acquisition of three lithium projects in Brazil’s Lithium Valley, confirming high-grade spodumene mineralisation and advancing drilling plans for Q2 2025. Metallurgical tests at its Raptor Rare Earth Project show strong recoveries of critical magnet rare earth elements.

Pointerra Limited’s Q3 FY25 results reveal delayed invoicing milestones pushed into Q4, yet strong progress across multiple sectors and promising product development underpin an optimistic cashflow outlook.

Narryer Metals reports compelling scandium, gallium, and rare earth assay results at its Rocky Gully Project, alongside advancing a titanium-rich heavy mineral sands discovery through its JV with Petratherm at Muckanippie.

Zoono Group Limited reports strong progress in its shelf-life extension technology trials across multiple continents, with successful UK supermarket trials paving the way for a national roll-out in FY26. Despite a quarterly operating cash outflow, the company expects improved sales and sufficient funding to meet its near-term objectives.

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.

Energy Action Ltd reported a robust 22.7% increase in revenue to $2.7 million for Q3 FY25, alongside positive operating cash flow and continued investment in its AI-driven Utilibox platform, signaling strong momentum in energy management innovation.

Alchemy Resources reported significant progress at its Karonie Gold-Lithium Project with JOGMEC completing its $600,000 farm-in commitment and over 4,000 soil samples analyzed, identifying 12 priority targets for follow-up. Meanwhile, strong copper and gold assays at Lachlan’s Yellow Mountain prospect and regained Bryah Basin control underscore a busy quarter.

Perseus Mining Limited delivered a robust March 2025 quarter with steady gold production, strong cash flow, and key project milestones including FIDs for the CMA Underground and Nyanzaga Gold projects.